Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “1- Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05386472
What this trial is testing

Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

Who this might be right for
COVID-19
Pfizer 25
Early research (Phase 1)Study completedNCT03745144
What this trial is testing

Effects of Cladribine Tablets on the PK of Microgynon®

Who this might be right for
Relapsing Multiple Sclerosis (RMS)
Merck KGaA, Darmstadt, Germany 28
Large-scale testing (Phase 3)Study completedNCT02017171
What this trial is testing

Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes

Who this might be right for
Diabetic NephropathiesCoronary Artery Disease
Alessandro Doria 530
Testing effectiveness (Phase 2)Looking for participantsNCT07189871
What this trial is testing

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more
Radiopharm Theranostics, Ltd 61
Early research (Phase 1)Study completedNCT02161796
What this trial is testing

Evaluate the Dose-proportionality and Effects of FG-4592 in Healthy Young and Elderly Male and Female Subjects

Who this might be right for
PK for FG-4592Healthy Subjects
Astellas Pharma Europe B.V. 48
Large-scale testing (Phase 3)Study completedNCT04987203
What this trial is testing

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
AVEO Pharmaceuticals, Inc. 343
Testing effectiveness (Phase 2)Study completedNCT01727089
What this trial is testing

Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer+2 more
National Cancer Institute (NCI) 59
Early research (Phase 1)Study completedNCT06554574
What this trial is testing

Single and Multiple Ascending Dose Study of LTG-305 Administered Orally in Healthy Participants

Who this might be right for
Healthy
Latigo Biotherapeutics 112
Very early researchStudy completedNCT06135974
What this trial is testing

Vaginal lIve Biotherapeutic RANdomized Trial

Who this might be right for
Bacterial Vaginosis
Massachusetts General Hospital 24
Early research (Phase 1)Ended earlyNCT00937482
What this trial is testing

Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Male Breast CancerStage IV Breast CancerStage IV Melanoma+7 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Ended earlyNCT00736788
What this trial is testing

Assess Safety, Tolerability and Pharmacokinetic (PK) of AZD1704 in Healthy Japanese Male and Non-Fertile Female Volunteers

Who this might be right for
Healthy Volunteers
AstraZeneca 16
Testing effectiveness (Phase 2)Looking for participantsNCT06413680
What this trial is testing

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Who this might be right for
MelanomaClear-Cell Renal-Cell Carcinoma (ccRCC)Advanced Solid Tumors
Regeneron Pharmaceuticals 240
Early research (Phase 1)Study completedNCT06496217
What this trial is testing

Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function

Who this might be right for
Renal Impairment
MBX Biosciences 25
Post-approval studies (Phase 4)Study completedNCT01656135
What this trial is testing

Reference Group Trial for The ONE Study

Who this might be right for
End-stage Renal FailureKidney Graft Rejection
University of Regensburg 70
Early research (Phase 1)Study completedNCT05117294
What this trial is testing

ASP0367 in People With Kidneys That do Not Work Well and in Healthy People

Who this might be right for
Renal ImpairmentHealthy Volunteers
Astellas Pharma Global Development, Inc. 13
Early research (Phase 1)Study completedNCT02275156
What this trial is testing

Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab

Who this might be right for
HyperlipidemiaMixed Dyslipidemia
Amgen 18
Early research (Phase 1)Study completedNCT00674856
What this trial is testing

A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function

Who this might be right for
Renal Failure
NicOx 32
Large-scale testing (Phase 3)Active Not RecruitingNCT04716231
What this trial is testing

Atacicept in Subjects With IgA Nephropathy

Who this might be right for
IgA NephropathyBerger Disease
Vera Therapeutics, Inc. 376
Testing effectiveness (Phase 2)Looking for participantsNCT06638931
What this trial is testing

Agnostic Therapy in Rare Solid Tumors

Who this might be right for
Urachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more
Instituto do Cancer do Estado de São Paulo 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT06307431
What this trial is testing

Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 272
Next Page